Saturday, September 3, 2016
FDA Approves OxyContin for Children as Young as 11
The Food and Drug Administration has approved limited use of the powerful and frequently abused painkiller OxyContin for children as young as 11 years old, the agency announced Thursday.
Dr. Sharon Hertz, director of new anesthesia, analgesia and addiction products for the FDA, said studies by Purdue Pharma of Stamford, Connecticut, which manufactures the drug, "supported a new pediatric indication for OxyContin in patients 11 to 16 years old and provided prescribers with helpful information about the use of OxyContin in pediatric patients."
OxyContin is a long-release version of oxycodone, an opioid that acts on the brain like heroin and is intended for only the most severe and chronic pain cases.
Because oxycodone and other opioids are extremely powerful and highly addictive, they're very tightly regulated — and very popular with addicts and pill pushers.
In this podcast you will hear:
The potential of a functional medicine micropractice focused on healing pain.
The language of pain and how to speak to your patients about it.
How chronic pain affects about 100 million people in the U.S.
The brain is the cause of pain – what can we do to dampen that pain response?
The epidemic problem with opioids and the CDC/NIH stance.